Literature DB >> 14960649

Quantitative analysis of 99mTc-DMSA during acute pyelonephritis for prediction of long-term renal scarring.

Anne Hitzel1, Agnès Liard, Jean-Nicolas Dacher, Isabelle Gardin, Jean-François Ménard, Alain Manrique, Pierre Véra.   

Abstract

UNLABELLED: This study was performed to evaluate a quantitative method based on (99m)Tc-DMSA renal planar scintigraphy performed during acute pyelonephritis (APN) to detect kidneys at risk of scarring.
METHODS: A total of 43 children (5.8 +/- 3.6 y old [mean +/- SD]) were examined by (99m)Tc-DMSA scintigraphy during (DMSA 1) and 8 +/- 2 mo after (DMSA 2) APN. Two levels of interpretation were performed independently: first, a semiquantitative analysis to classify the kidneys by considering the evolution between DMSA 1 and DMSA 2 (i.e., to determine which kidneys had developed scarring), and second, an automatic quantitative analysis of DMSA 1 to define and to evaluate a predictive index for kidney evolution from DMSA 1 to DMAS 2. The method consisted of determining an automatic threshold for the kidney and then calculating ratios of the count density in a given isocount n% (region of interest containing all the pixels with a value > or = n% of the value of the pixel with the maximal activity value) to the count density in a 20% isocount (C(n%)) and the number of pixels in a given isocount to the number of pixels in a 20% isocount (S(n%)).
RESULTS: All kidneys normal at DMSA 1 remained normal at DMSA 2. For the automatic index, the C(70%) ratio was considered the best index for the prediction of scarring. When this C(70%) ratio was used, a cutoff value of 0.45 was able to predict scarring with a sensitivity of 0.83, a specificity of 0.78, a positive predictive value of 0.85, and a negative predictive value of 0.77.
CONCLUSION: A cutoff value of 0.45 for the C(70%) ratio calculated for (99m)Tc-DMSA scintigraphy performed during APN may be useful for detecting kidneys at risk of scarring.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14960649

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  7 in total

Review 1.  Imaging studies after a first febrile urinary tract infection in young children.

Authors:  Richard Schlussel
Journal:  Curr Urol Rep       Date:  2005-03       Impact factor: 3.092

Review 2.  Mapping COVID-19 functional sequelae: the perspective of nuclear medicine.

Authors:  Simone Cristina Soares Brandão; Júlia de Oliveira Xavier Ramos; Gustavo Freitas Alves de Arruda; Emmanuelle Tenório Albuquerque Madruga Godoi; Lara Cristiane Terra Ferreira Carreira; Rafael Willain Lopes; Gabriel Blacher Grossman; Ronaldo de Souza Leão Lima
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-12-15

Review 3.  Imaging strategies in pediatric urinary tract infection.

Authors:  Jean-Nicolas Dacher; Anne Hitzel; Fred E Avni; Pierre Vera
Journal:  Eur Radiol       Date:  2005-03-24       Impact factor: 5.315

4.  New strategy of color and power doppler sonography combined with DMSA in the assessment of acute pyelonephritis in infants.

Authors:  Min Guang Chen; Yan Yang; Qing Yang; Jie Qiu Zhuang; Xiao Hua Ye; Wen Jie Zheng
Journal:  BMC Nephrol       Date:  2021-05-17       Impact factor: 2.388

5.  Comparison of the Relative Renal Function Calculated with 99mTc-Diethylenetriaminepentaacetic Acid and 99mTc-Dimercaptosuccinic Acid in Children.

Authors:  Tanju Çelik; Hülya Yalçin; Emel Ceylan Günay; Aynur Özen; Cahit Özer
Journal:  World J Nucl Med       Date:  2014-09

6.  Can Tc 99m DTPA be Used in Adult Patients in Evaluation of Relative Renal Function Measurement as the Reference Tc 99m DMSA Method?

Authors:  Hülya Yalçın; Aynur Ozen; Emel Ceylan Günay; Inci Aliç Ozaslan; Cahit Ozer
Journal:  Mol Imaging Radionucl Ther       Date:  2011-04-01

7.  Semiquantitative analysis of power doppler ultrasonography versus Tc-99m DMSA scintigraphy in diagnostic and severity assessment of acute childhood pyelonephritis.

Authors:  Hui Zhu; Minguang Chen; Hongxia Luo; Yin Pan; Wenjie Zheng; Yan Yang
Journal:  Transl Pediatr       Date:  2020-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.